The Phase III trial AV001 aims to evaluate QUTENZA® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical ...

There can be no assurance regarding the schedule for completion of ... receptor modulator being developed as a potential treatment for acute and chronic neuropathic pain secondary to diabetic ...

Vitamins and mineral supplements can help address nutritional deficiencies that commonly affect people who have Crohn’s ...